Does NATALIZUMAB Cause Lymphadenopathy? 90 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Lymphadenopathy have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.1% of all adverse event reports for NATALIZUMAB.
90
Reports of Lymphadenopathy with NATALIZUMAB
0.1%
of all NATALIZUMAB reports
3
Deaths
30
Hospitalizations
How Dangerous Is Lymphadenopathy From NATALIZUMAB?
Of the 90 reports, 3 (3.3%) resulted in death, 30 (33.3%) required hospitalization, and 7 (7.8%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which NATALIZUMAB Alternatives Have Lower Lymphadenopathy Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK